Stress stability studies on semaglutide have demonstrated that the peptide remains relatively stable for 28 days at temperatures up to 25 degrees Celsius and shows significant degradation at 40 degrees Celsius within the same timeframe
American Journal of Physiology-Endocrinology and Metabolism, 285 (1), E12-E20
It also affects gastrointestinal distension, which further lessens the appetite between feeding times [10, 16, 17]
Others find that the appetite regulation benefits of GLP-1 therapy, combined with habits built during treatment, allow them to maintain results after stopping
For some, the right path may simply include GLP1 medications such as Ozempic or Tirzepatide
DHA reduction, through scavenging GSH, induces oxidative stress, leading to GAPDH inactivation, inhibition of glycolysis and the subsequent energy crisis and cell death